Thomas G. Wiggans
2017 - Dermira
In 2017, Thomas G. Wiggans earned a total compensation of $5.8M as Chief Executive Officer at Dermira, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $393,750 |
|---|---|
| Option Awards | $3,871,770 |
| Salary | $525,000 |
| Stock Awards | $1,015,200 |
| Total | $5,805,720 |
Wiggans received $3.9M in option awards, accounting for 67% of the total pay in 2017.
Wiggans also received $393.8K in non-equity incentive plan, $525K in salary and $1M in stock awards.
Rankings
In 2017, Thomas G. Wiggans' compensation ranked 1,531st out of 14,666 executives tracked by ExecPay. In other words, Wiggans earned more than 89.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,531 out of 14,666 | 90th |
Division Manufacturing | 515 out of 5,772 | 91st |
Major group Chemicals And Allied Products | 136 out of 2,075 | 93rd |
Industry group Drugs | 98 out of 1,731 | 94th |
Industry Pharmaceutical Preparations | 77 out of 1,333 | 94th |
Source: SEC filing on April 24, 2019.
Wiggans' colleagues
We found three more compensation records of executives who worked with Thomas G. Wiggans at Dermira in 2017.